Drug Type Small molecule drug |
Synonyms meropenem + piperacillin + tazobactam (Viosera Therapeutics) |
Action inhibitors |
Mechanism Penicillin binding protein 1A inhibitors, Penicillin binding protein 2 inhibitors, β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Staphylococcal Infections | Preclinical | United States | - | |
Staphylococcal Infections | Preclinical | United States | - |